Search

everythinglearnresearchcommunity

for

Search:↓

People with androgenetic alopecia are more likely to have metabolic syndrome.

The document talks about three main surgical treatments for hair loss: punch hair transplantation, alopecia reduction, and flap hair transplantation.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Follicular Unit Transplantation (FUT) can give great results and patient satisfaction when done carefully and by a skilled surgeon.

Men need higher doses and tailored injection techniques for botulinum toxin treatments due to their unique facial features.

Use a frontal forelock pattern to manage advanced hair loss.

Hair transplantation using micrografts and minigrafts is effective and safe for facial and scalp reconstruction with natural-looking results.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Unsatisfactory hair restoration results can be significantly improved with strategic hair redistribution and new donor hair placement, despite previous surgery challenges.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Low dose finasteride doesn't change lipid profile or metabolic parameters in mice.

Finasteride improves hair loss in women with hyperandrogenism.

Men who think they are losing hair feel worse about themselves, especially if they are younger.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

The document concludes that hair transplantation is recommended for those not helped by medical treatments, but warns that high-density transplants may lower hair survival rates.

New compounds may soon be tested to treat excessive hair growth in women.

Hair restoration surgery can have complications; success depends on patient education, careful planning, and proper execution.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Acceptance reduces hair loss distress and medical consultations; coping mechanisms increase them.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Hair transplantation has improved with techniques that increase graft survival and patient satisfaction for more natural results.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.

Female pattern hair loss treatments vary in effectiveness and may have side effects.